skip to primary navigationskip to content

Virtual fitting room Metail closes $12m funding round

last modified Oct 27, 2014 04:34 PM
Virtual fitting room Metail has recently closed on a $12 million funding round, adding to $8 million raised since being founded in 2008.


Metail, one of the ideaSpace City site alumni firms, allows you to create a 3D version of yourself so you can shop online and virtually try on clothes.

Using just a few simple measurements, Metail is able to deliver a 94-96% accurate 3D model of you, called a MeModel, complete with hairstyle and skin tone. More and more people are experimenting with how new styles and clothes would look on their MeModel from the comfort of their own home.

The lead investor in this new round is TAL Apparel, of Hong Kong-based TAL Group, a global leader in garment manufacturing.

Tom Adeyoola, co-founder and CEO, said the long-term vision is for Metail is to become the ‘Google of sizing and shape’.

To find out more, visit here.

For more information on Metail, visit

RSS Feed Latest news

ideaSpace 'Dream Team' Fronteer, featured in E-Learn Magazine

Oct 24, 2016

E-Learning magazine champions Fronteer's new product 'Ally', which makes course content more accessible for students and instructors.

Two ideaSpace Companies Scoop Prizes at the 7th Annual Discovering Start-Ups Competition!

Oct 21, 2016

Congratulations to ideaSpace members 8Power and Focal Point Positioning who have been announced as winners of the 2016 Cambridge Wireless Discovering Start-Ups competition, along with risk analytics company, AlgoDynamix.

Polysolar celebrate Top Innovation Award

Oct 10, 2016

Polysolar who develop, design, and project-manage Building Integrated Photovoltaic (BIPV) solutions have won Cambridge News Top Innovation 2016 Award

Healx secures £1.5m from Amadeus Capital and investors to combat rare diseases

Oct 05, 2016

Amadeus Capital Partners, the global technology investor, has made an early-stage investment of £1.5 million in ideaSpace alumni Healx, a Cambridge based healthcare company that seeks new uses for existing drugs in the fight against rare diseases.

View all news